Monosan

What Monosan does

Monosan is a Dutch life science research brand operated by Sanbio B.V., a privately held private limited company headquartered at Frontstraat 2c, 5405 PB Uden, the Netherlands. The company was established in 1979 when it began marketing the first Anti-Rat T-cell monoclonal antibody, and has since built a 40+ year catalog of research antibodies and reagents serving the life science research community globally. Under the MONOSAN® registered trademark, Sanbio B.V. maintains three active certifications: ISO 9001 (quality management), ISO 14001 (environmental management), and an Ecovadis sustainability rating valid until June 2026.

The company's product portfolio is organized into four sub-brands: MONOSAN (core monoclonal and polyclonal antibodies), MONOSAN Ready to Use (pre-diluted antibodies optimized for immunohistochemistry), MONOSAN Reagents (cytokines, growth factors, and phytocannabinoids), and MONOSAN Xtra (extended antibody variants). The catalog is further categorized into Primary Antibodies, Secondary Antibodies, and Ancillaries, with an OEM/Bulk service line offering custom manufacturing and large-volume supply to commercial partners. Distribution is executed through three named regional distributors — Sapphire Bioscience in Australia, Newmarket Scientific in the United Kingdom, and Cedarlane in Canada — alongside direct e-commerce sales via monosan.com and a marketplace listing on Scientist.com. The company also maintains a GTM partnership with BenchSci to augment the visibility and purchasability of its IHC antibodies through that platform's research procurement tool.

Monosan's revenue mechanics are based on the one-time sale of antibodies and reagents to research institutions, academic laboratories, and pharmaceutical companies, with pricing handled on a quote basis rather than a publicly disclosed schedule. No funding events, headcount figures, or revenue figures are publicly disclosed, and the company has remained privately held under Sanbio B.V. since its founding. Operating geographies are explicitly identified as Europe (Netherlands), with additional reach into Australia, the United Kingdom, and Canada via the distributor network. Marketing channels are primarily digital — the corporate website, LinkedIn and Twitter presence, and an email newsletter aggregated at the Sanbio parent level.

Name

Monosan

Legal name

Sanbio B.V.

Website

https://monosan.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

11–50 employees

Short description

Monosan is a Dutch brand of Sanbio B.V. that supplies monoclonal and polyclonal antibodies, ready-to-use IHC reagents, and OEM/bulk antibody services to academic, research, and pharmaceutical life science laboratories globally through regional distributors and direct e-commerce.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Research antibodies
• Monoclonal antibodies
• Polyclonal antibodies
• Immunohistochemistry reagents
• Life science reagents

Headquarters

HQ city

Uden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Antibody and Reagent Sales: Monosan generates revenue through the sale of research antibodies and reagents including primary antibodies, secondary antibodies, and ancillaries to life science research institutions worldwide.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

MONOSAN manufactures and supplies research-grade antibodies and reagents for the life science research community. The portfolio includes monoclonal and polyclonal primary antibodies, secondary antibodies, ancillaries, ready-to-use immunohistochemistry formulations, and cytokines, growth factors, and phytocannabinoids. OEM and bulk antibody manufacturing and licensing services are also offered to commercial partners.

Product overview

MONOSAN is a brand name of Sanbio B.V. based in the Netherlands, offering a comprehensive portfolio of antibodies and reagents for life science research. The product line is organized into four main sub-brands: MONOSAN (core antibodies), MONOSAN Ready to Use (pre-diluted formulations), MONOSAN Reagents (cytokines, growth factors, and specialized reagents), and MONOSAN Xtra (extended variants). The portfolio is further categorized into Primary Antibodies, Secondary Antibodies, and Ancillaries. The company has over 40 years of experience, having launched its first Anti-Rat T-cell monoclonal antibody in 1979. Additionally, OEM and bulk antibody production services are available for commercial partnerships.

Differentiator

Problem solved

Functional benefit

Brands

• MONOSAN Ready to Use: Ready to use antibodies product line
• MONOSAN Reagents
• MONOSAN Xtra

Products and services

• Primary Antibodies Monoclonal and polyclonal antibodies targeting various antigens for life science research applications, sold to academic institutions, research laboratories, and pharmaceutical companies.
• Secondary Antibodies Secondary antibodies for detection and visualization in various assay formats, used by life science researchers.
• Ancillaries Supporting reagents and supplies for antibody-based applications, including detection kits and buffers.
• MONOSAN Ready to Use Antibodies Pre-diluted, ready-to-use antibody formulations optimized for immunohistochemistry applications, providing convenience and ease of use for researchers.
• MONOSAN Reagents Specialized reagents including cytokines, growth factors, and phytocannabinoids for research applications.
• MONOSAN Xtra Extended product line offering additional antibody variants and formulations.
• OEM / Bulk Antibodies Large-scale antibody manufacturing and bulk supply service for commercial partners.
• Antibody Licensing Licensing of MONOSAN antibodies for commercial use by partners.

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Sanbio B.V.coreOthersSanbio B.V. is the parent company of the MONOSAN brand. MONOSAN is a brand name of Sanbio B.V. in the Netherlands, marketing antibodies and reagents to the life science research community since 1979.
• BenchSciminorGTM or Marketing PartnerPartnership to augment visibility and purchasability of IHC (immunohistochemistry) antibodies through BenchSci's platform.
• Sapphire Bioscience Pty. Ltd.minorChannel Partner/ Reseller/ DistributorRegional distributor of MONOSAN products in Australia
• Newmarket ScientificminorChannel Partner/ Reseller/ DistributorRegional distributor of MONOSAN products in the United Kingdom
• CedarlaneminorChannel Partner/ Reseller/ DistributorRegional distributor of MONOSAN products in Canada, valued for the relationship and product offering
• Scientist.comminorChannel Partner/ Reseller/ DistributorMarketplace listing where some MONOSAN products are available for purchase

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Abcam: Abcam is one of the largest global catalog research antibody suppliers, offering primary and secondary antibodies for life science research. It is the most directly comparable peer to MONOSAN in product category, customer base (academic and pharma researchers), and distribution model.
• Cell Signaling Technology: Cell Signaling Technology is a leading specialty antibody company focused on signaling pathways and IHC applications. It directly competes with MONOSAN in monoclonal antibody research reagents and IHC-ready-to-use formats.
• BioLegend: BioLegend is a specialty antibody and reagent supplier focused on immunology and cell biology research, directly competing with MONOSAN in primary antibodies and ancillary reagents for life science researchers.
• Atlas Antibodies: Atlas Antibodies specializes in monoclonal antibodies and protein atlas reagents for research, directly comparable to MONOSAN's monoclonal antibody catalog and IHC-ready offerings.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established catalog supplier of monoclonal and polyclonal antibodies for research applications, competing head-to-head with MONOSAN's core catalog offerings to academic and industry researchers.
• Proteintech: Proteintech is a fast-growing antibody manufacturer with a deep catalog of primary antibodies and reagents for life science research. It is a direct peer in catalog antibody sales, with overlapping customer segments and similar OEM/bulk capabilities.

Broad incumbents

• Merck (MilliporeSigma): MilliporeSigma, the life science arm of Merck, offers an extensive catalog of antibodies, reagents, and biochemicals. It overlaps with MONOSAN's product lines as a broad incumbent serving academic and industrial research customers.
• Thermo Fisher Scientific (Invitrogen): Invitrogen, part of Thermo Fisher Scientific, is a dominant life science tools brand offering antibodies and reagents alongside a much broader instrument and consumables portfolio. It overlaps with MONOSAN's catalog but competes from a vastly larger commercial footprint.
• Bio-Techne (R&D Systems / Novus Biologicals): Bio-Techne operates R&D Systems and Novus Biologicals, both direct competitors in research antibodies, cytokines, and reagents. It is a broad incumbent with multiple overlapping product lines serving similar life science research customers.

Others

• Scientist.com: Scientist.com is a research-services marketplace where MONOSAN lists its products. It is an ecosystem/distribution partner rather than a competitor, but relevant as a channel through which MONOSAN reaches enterprise research buyers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/MonosanAbs
• LinkedInlinkedin.com/company/3493130

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monosan